Acta Neuropathologica

, Volume 108, Issue 6, pp 476–484

Loss of glycosylation associated with the T183A mutation in human prion disease

  • E. Grasbon-Frodl
  • Holger Lorenz
  • U. Mann
  • R. M. Nitsch
  • Otto Windl
  • H. A. Kretzschmar
Regular Paper

Abstract

A heterozygous T183A mutation in the prion protein (PrP) gene, PRNP, was identified in a patient with histopathologically confirmed spongiform encephalopathy. Clinically, this form of prion disease was characterized by early-onset dementia as the predominant sign, along with global cerebral atrophy and hypometabolism. The age at onset was 40 years and the disease duration was 4 years. Additional neurological signs including cerebellar ataxia and EEG abnormalities were absent until late stages of the disease. The T183A mutation was not found in non-affected family members. This mutation results in the removal of one of the two consensus sites for glycosylation of PrP. Neuropathological examination revealed severe spongiform degeneration and neuronal loss in the neocortex, putamen and claustrum, small plaque-like PrP-immunoreactive deposits in the molecular layer of the cerebellum, and faint intracellular cytoplasmic PrP immunoreactivity. Western blot analysis of the patient’s brain tissue showed protease K-resistant PrP with a definite preponderance of the monoglycosylated form. The additional appearance of a band representing diglycosylated PrPSc strongly suggests that non-mutated PrP also acquires protease resistance in the present setting. Cell culture experiments confirmed previous reports on intracellular retention of the mutant protein in vitro. This is the second report of a disease-causing T183A mutation of PrP, and the clinical, histological and genetic observations strongly suggest that T183A is a disease-causing mutation.

Keywords

Prion disease Familial Creutzfeldt-Jakob-disease Mutation Glycosylation-T183A 

References

  1. 1.
    Boellaard JW, Doerrschott J, Schlote W (1993) Miniplaques and shapeless cerebral amyloid deposits in a case of Gerstmann-Straussler-Scheinker’s syndrome. Acta Neuropathol 86:532–535PubMedGoogle Scholar
  2. 2.
    Brown P, Wolff A, Gajdusek DC (1990) A simple and effective method for inactivating virus infectivity in formalin-fixed tissue samples from patients with Creutzfeldt-Jakob disease. Neurology 40:887–890PubMedGoogle Scholar
  3. 3.
    Capellari S, Zaidi SI, Long AC, Kwon EE, Petersen RB (2000) The Thr183Ala mutation, not the loss of the first glycosylation site, alters the physical properties of the prion protein. J Alzheimers Dis 2:27–35PubMedGoogle Scholar
  4. 4.
    Chen SG, Parchi P, Brown P, Capellari S, Zou W, Cochran EJ, Vnencak-Jones CL, Julien J, Vital C, Mikol J, Lugaresi E, Gambetti P (1997) Allelic origin of the abnormal prion protein isoform in familial prion diseases. Nat Med 3:1009–1015CrossRefPubMedGoogle Scholar
  5. 5.
    Collinge J, Brown J, Hardy J, Mullan M, Rossor MN, Baker H, Crow TJ, Lofthouse R, Poulter M, Ridley R, et al (1992) Inherited prion disease with 144 base pair gene insertion. 2. Clinical and pathological features. Brain 115:687–710PubMedGoogle Scholar
  6. 6.
    DeArmond S, Sanchez H, Yehiely F, Qiu Y, Ninchak-Casey A, Daggett V, Camerino AP, Cayetano J, Rogers M, Groth D, Torchia M, Tremblay P, Scott MR, Cohen FE, Prusiner SB (1997) Selective neuronal targeting in prion disease. Neuron 19:1337–1348CrossRefPubMedGoogle Scholar
  7. 7.
    DeArmond SJ, Bouzamondo E (2002) Fundamentals of prion biology and diseases. Toxicology 181–182:9–16Google Scholar
  8. 8.
    Finckh U, ller-Thomsen T, Mann U, Eggers C, Marksteiner J, Meins W, Binetti G, Alberici A, Hock C, Nitsch RM, Gal A (2000) High prevalence of pathogenic mutations in patients with early-onset dementia detected by sequence analyses of four different genes. Am J Hum Genet 66:110–117CrossRefPubMedGoogle Scholar
  9. 9.
    Fisher CL, Pei GK (1997) Modification of a PCR-based site-directed mutagenesis method. Biotechniques 23:570–574PubMedGoogle Scholar
  10. 10.
    Folstein MF, Folstein SE, McHugh PR (1975) “Mini-mental state”. A practical method for grading the cognitive state of patients for the clinician. J Psychiatr Res 12:189–198CrossRefPubMedGoogle Scholar
  11. 11.
    Gabizon R, Telling G, Meiner Z, Halimi M, Kahana I, Prusiner SB (1996) Insoluble wild-type and protease-resistant mutant prion protein in brains of patients with inherited prion disease. Nat Med 2:59–64CrossRefPubMedGoogle Scholar
  12. 12.
    Ghetti B, Dlouhy SR, Giaccone G, Bugiani O, Frangione B, Farlow MR, Tagliavini F (1995) Gerstmann-Sträussler-Scheinker disease and the Indiana kindred. Brain Pathol 5:61–75PubMedGoogle Scholar
  13. 13.
    Goldfarb LG, Petersen RB, Tabaton M, Brown P, Leblanc AC, Montagna P, Cortelli P, Julien J, Vital C, Pendelbury WW, Haltia M, Wills PR, Hauw JJ, McKeever PE, Monari L, Schrank B, Swergold GD, Gajdusek DC, Lugaresi E, Gambetti P (1992) Fatal familial insomnia and familial Creutzfeldt-Jakob disease: disease phenotype determined by a DNA polymorphism. Science 258:806–808PubMedGoogle Scholar
  14. 14.
    Hainfellner J-A, Parchi P, Kitamoto T, Jarius C, Gambetti P, Budka H (1999) A novel phenotype in familial Creutzfeldt-Jakob disease: prion protein gene E200K mutation coupled with valine at codon 129 and type 2 protease-resistant prion protein. Ann Neurol 45:812–815CrossRefPubMedGoogle Scholar
  15. 15.
    Hamasaki S, Shirabe S, Tsuda R, Yoshimura T, Nakamura T, Eguchi K (1998) Discordant Gerstmann-Straussler-Scheinker disease in monozygotic twins. Lancet 352:1358–1359Google Scholar
  16. 16.
    Hill AF, Joiner S, Wadsworth JD, Sidle KC, Bell JE, Budka H, Ironside JW, Collinge J (2003) Molecular classification of sporadic Creutzfeldt-Jakob disease. Brain 126:1333–1346CrossRefPubMedGoogle Scholar
  17. 17.
    Ivanova L, Barmada S, Kummer T, Harris DA (2001) Mutant prion proteins are partially retained in the endoplasmic reticulum. J Biol Chem 276:42409–42421CrossRefPubMedGoogle Scholar
  18. 18.
    Kascsak RJ, Rubenstein R, Merz PA, Tonna-DeMasi M, Fersko R, Carp RI, Wisniewski HM, Diringer H (1987) Mouse polyclonal and monoclonal antibody to scrapie-associated fibril proteins. J Virol 61:3688–3693PubMedGoogle Scholar
  19. 19.
    Klebe RJ, Ruddle FH (1969) Neuroblastoma: cell culture analysis of a differentiating stem cell system. J Cell Biol 43:69aGoogle Scholar
  20. 20.
    Kovacs GG, Trabattoni G, Hainfellner JA, Ironside JW, Knight RS, Budka H (2002) Mutations of the prion protein gene phenotypic spectrum. J Neurol 249:1567–1582Google Scholar
  21. 21.
    Kretzschmar HA, Sethi S, Foldvari Z, Windl O, Querner V, Zerr I, Poser S (2003) Iatrogenic Creutzfeldt-Jakob disease with florid plaques. Brain Pathol 13:245–249PubMedGoogle Scholar
  22. 22.
    Lehmann S, Harris DA (1997) Blockade of glycosylation promotes acquisition of scrapie-like properties by the prion protein in cultured cells. J Biol Chem 272:21479–21487CrossRefPubMedGoogle Scholar
  23. 23.
    Liemann S, Glockshuber R (1999) Influence of amino acid substitutions related to inherited human prion diseases on the thermodynamic stability of the cellular prion protein. Biochemistry 38:3258–3267CrossRefPubMedGoogle Scholar
  24. 24.
    Lorenz H, Windl O, Kretzschmar HA (2001) Cellular phenotyping of secretory and nuclear prion proteins associated with inherited prion diseases. J Biol Chem 277:8508–8516CrossRefPubMedGoogle Scholar
  25. 25.
    Luhrs T, Riek R, Guntert P, Wuthrich K (2003) NMR structure of the human doppel protein. J Mol Biol 326:1549–1557CrossRefPubMedGoogle Scholar
  26. 26.
    McKhann G, Drachman D, Folstein M, Katzman R, Price D, Stadlan EM (1984) Clinical diagnosis of Alzheimer’s disease: report of the NINCDS-ADRDA Work Group under the auspices of Department of Health and Human Services Task Force on Alzheimer’s Disease. Neurology 34:939–944PubMedGoogle Scholar
  27. 27.
    Negro A, Ballarin C, Bertoli A, Massimino ML, Sorgato MC (2001) The Metabolism and imaging in live cells of the bovine prion protein in its native form or carrying single amino acid substitutions. Mol Cell Neurosci 17:521–538Google Scholar
  28. 28.
    Nitrini R, Rosemberg S, Passos-Bueno MR, Teixeira da Silva LS, Iughetti P, Papadopoulos M, Carrilho PM, Caramelli P, Albrecht S, Zatz M, et al. (1997) Familial spongiform encephalopathy associated with a novel prion protein gene mutation. Ann Neurol 42:138–146PubMedGoogle Scholar
  29. 29.
    Nixon R, Camicioli R, Jamison K, Cervenakova L, Mastrianni JA (2000) The PRNP-V180I mutation is associated with abnormally glycosylated PrP and intracellular PrP accumulations. Brain Pathol 10:670Google Scholar
  30. 30.
    Owen F, Poulter M, Shah T, Collinge J, Lofthouse R, Baker H, Ridley R, McVey J, Crow TJ (1990) An in-frame insertion in the prion protein gene in familial Creutzfeldt-Jakob disease. Mol Brain Res 7:273–276Google Scholar
  31. 31.
    Parchi P, Chen SG, Brown P, Zou WQ, Capellari S, Budka H, Hainfellner J, Reyes PF, Golden GT, Hauw J-J, et al (1998) Different patterns of truncated prion protein fragments correlate with distinct phenotypes in P102L Gerstmann-Straussler-Scheinker disease. Proc Natl Acad Sci USA 95:8322–8328CrossRefPubMedGoogle Scholar
  32. 32.
    Parchi P, Petersen RB, Chen SG, Autillo-Gambetti L, Capellari S, Monari L, Cortelli P, Montagna P, Lugaresi E, Gambetti P (1998) Molecular pathology of fatal familial insomnia. Brain Pathol 8:539–548PubMedGoogle Scholar
  33. 33.
    Parchi P, Giese A, Capellari S, Brown P, Schulz-Schaeffer W, Windl O, Zerr I, Budka H, Kopp N, Piccardo P, Poser S, Rojiani A, Streichemberger N, Julien J, Vital C, Ghetti B, Gambetti P, Kretzschmar H (1999) Classification of sporadic Creutzfeldt-Jakob disease based on molecular and phenotypic analysis of 300 subjects. Ann Neurol 46:224–233CrossRefPubMedGoogle Scholar
  34. 34.
    Riek R, Wider G, Billeter M, Hornemann S, Glockshuber R, Wüthrich K (1998) Prion protein NMR structure and familial human spongiform encephalopathies. Proc Natl Acad Sci USA 95:11667–11672CrossRefPubMedGoogle Scholar
  35. 35.
    Rogers M, Taraboulos A, Scott M, Groth D, Prusiner SB (1990) Intracellular accumulation of the cellular prion protein after mutagenesis of its Asn-linked glycosylation sites. Glycobiology 1:101–109PubMedGoogle Scholar
  36. 36.
    Rudd PM, Wormald MR, Wing DR, Prusiner SB, Dwek RA (2001) Prion glycoprotein: structure, dynamics, and roles for the sugars. Biochemistry 40:3759–3766CrossRefPubMedGoogle Scholar
  37. 37.
    Silvestrini MC, Cardone F, Maras B, Pucci P, Barra D, Brunori M, Pocchiari M (1997) Identification of the prion protein allotypes which accumulate in the brain of sporadic and familial Creutzfeld-Jakob disease patients. Nat Med 3:521–525CrossRefPubMedGoogle Scholar
  38. 38.
    Tagliavini F, Prelli F, Porro M, Rossi G, Giaccone G, Farlow MR, Dlouhy SR, Ghetti B, Bugiani O, Frangione B (1994) Amyloid fibrils in Gerstmann-Straussler-Scheinker disease (Indiana and Swedish kindreds) express only PrP peptides encoded by the mutant allele. Cell 79:695–704CrossRefPubMedGoogle Scholar
  39. 39.
    Vorberg I, Buschmann A, Harmeyer S, Saalmüller A, Pfaff E, Groschup M (1999) A novel epitope for the specific detection of exogenous prion proteins in transgenic mice and transfected murine cell lines. Virology 255:26–31CrossRefPubMedGoogle Scholar
  40. 40.
    Windl O, Dempster M, Estibeiro JP, Lathe R, De Silva R, Esmonde T, Will R, Springbett A, Campbell TA, Sidle KCL, Palmer MS, Collinge J (1996) Genetic basis of Creutzfeldt-Jakob disease in the United Kingdom: a systematic analysis of predisposing mutations and allelic variations in the PRNP gene. Hum Genet 98:259–264CrossRefPubMedGoogle Scholar
  41. 41.
    Windl O, Giese A, Schulz-Schaeffer W, Skworc K, Arendt S, Oberdieck C, Bodemer M, Zerr I, Poser S, Kretzschmar HA (1999) Molecular genetics of human prion diseases in Germany. Hum Genet 105:244–252CrossRefPubMedGoogle Scholar
  42. 42.
    Young K, Clark HB, Piccardo P, Dlouhy SR, Ghetti B (1997) Gerstmann-Sträussler-Scheinker disease with the PRNP P102L mutation and valine at codon 129. Mol Brain Res 44:147–150CrossRefPubMedGoogle Scholar
  43. 43.
    Zahn R, Liu A, Luhrs T, Riek R, Schroetter C von, Lopez GF, Billeter M, Calzolai L, Wider G, Wuthrich K (2000) NMR solution structure of the human prion protein. Proc Natl Acad Sci USA 97:145–150CrossRefPubMedGoogle Scholar

Copyright information

© Springer-Verlag 2004

Authors and Affiliations

  • E. Grasbon-Frodl
    • 1
  • Holger Lorenz
    • 1
    • 2
  • U. Mann
    • 3
  • R. M. Nitsch
    • 4
  • Otto Windl
    • 1
    • 5
  • H. A. Kretzschmar
    • 1
  1. 1.Center for Neuropathology and Prion ResearchUniversity of MunichMünchenGermany
  2. 2.Cell Biology and Metabolism BranchNICHD, NIHBethesdaUSA
  3. 3.Department of NeurologyUniversity Hospital EppendorfHamburgGermany
  4. 4.Department for Psychiatric ResearchUniversity of ZürichZürichSwitzerland
  5. 5.TSE Molecular Biology DepartmentVeterinary Laboratories Agency-WeybridgeAddlestoneUK

Personalised recommendations